These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26995169)

  • 41. In brief: Higher-dose naloxone nasal spray (Kloxxado) for opioid overdose.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):151-152. PubMed ID: 34550963
    [No Abstract]   [Full Text] [Related]  

  • 42. Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals.
    Eswaran V; Allen KC; Bottari DC; Splawski JA; Bains S; Aks SE; Swoboda HD; Moore PQ; Tran TH; Salisbury-Afshar E; Lank PM; McCarthy DM; Kim HS
    Ann Emerg Med; 2020 Sep; 76(3):318-327. PubMed ID: 32241746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
    Beletsky L; Ruthazer R; Macalino GE; Rich JD; Tan L; Burris S
    J Urban Health; 2007 Jan; 84(1):126-36. PubMed ID: 17146712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Take home naloxone for opiate addicts. Big conclusions are drawn from little evidence.
    Mountain D
    BMJ; 2001 Oct; 323(7318):934; author reply 935. PubMed ID: 11693143
    [No Abstract]   [Full Text] [Related]  

  • 45. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Training and prescription of naloxone for personal use in overdose for opiate addicts.
    Barrie J
    Emerg Med J; 2008 Oct; 25(10):688-9. PubMed ID: 18843073
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of Formulation Variables on the Nasal Permeability and Stability of Naloxone Intranasal Formulations.
    Hsu HJ; Yang Y; Pavuluri V; Abraham C; Naraharisetti SB; Ashraf M; Al-Ghabeish M
    AAPS PharmSciTech; 2019 Jun; 20(6):232. PubMed ID: 31236738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
    Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
    Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caution with naloxone use in asthmatic patients.
    Allegretti PJ; Bzdusek JS; Leonard J
    Am J Emerg Med; 2006 Jul; 24(4):515-6. PubMed ID: 16787825
    [No Abstract]   [Full Text] [Related]  

  • 49. FDA approves first intranasal naloxone product.
    Traynor K
    Am J Health Syst Pharm; 2016 Jan; 73(1):e2-3. PubMed ID: 26683675
    [No Abstract]   [Full Text] [Related]  

  • 50. Take home naloxone for opiate addicts. Figures in Jersey give no support to scheme's effectiveness.
    Blackwood G
    BMJ; 2001 Oct; 323(7318):934-5; author reply 935. PubMed ID: 11693141
    [No Abstract]   [Full Text] [Related]  

  • 51. Scotland's National Naloxone Programme.
    Bird SM; McAuley A
    Lancet; 2019 Jan; 393(10169):316-318. PubMed ID: 30696566
    [No Abstract]   [Full Text] [Related]  

  • 52. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities.
    Coffin PO; Sullivan SD
    J Med Econ; 2013 Aug; 16(8):1051-60. PubMed ID: 23730942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County.
    Bode AD; Singh M; Andrews J; Kapur GB; Baez AA
    Am J Emerg Med; 2017 Sep; 35(9):1364-1365. PubMed ID: 28268113
    [No Abstract]   [Full Text] [Related]  

  • 54. The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy.
    Faulkner-Gurstein R
    Soc Sci Med; 2017 May; 180():20-27. PubMed ID: 28315595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heroin and naloxone.
    Lagoy A
    Am J Nurs; 2014 Oct; 114(10):12. PubMed ID: 25251107
    [No Abstract]   [Full Text] [Related]  

  • 56. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation.
    Williams AV; Strang J; Marsden J
    Drug Alcohol Depend; 2013 Sep; 132(1-2):383-6. PubMed ID: 23453260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Higher-Dose Naloxone Nasal Spray (Kloxxado) for Opioid Overdose.
    JAMA; 2021 Nov; 326(18):1853-1854. PubMed ID: 34751711
    [No Abstract]   [Full Text] [Related]  

  • 58. Emergency naloxone for heroin overdose: beware of naloxone's other characteristics.
    Ashworth AJ
    BMJ; 2006 Oct; 333(7571):754. PubMed ID: 17023478
    [No Abstract]   [Full Text] [Related]  

  • 59. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths.
    Gupta R; Shah ND; Ross JS
    N Engl J Med; 2016 Dec; 375(23):2213-2215. PubMed ID: 27959694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.